Stuart Duty

CIK: 0001970274

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)7 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (4)

FHTX

Foghorn Therapeutics Inc.

Director

MIST

Milestone Pharmaceuticals Inc.

Director

EYPT

EyePoint, Inc.

Director

ACHV

ACHIEVE LIFE SCIENCES, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

FHTX
Foghorn Therapeutics Inc.
Jun 24, 2026
Award(A)
Stock Options (Right to buy)
Direct
28K shares at avg. $4.08-
MIST
Milestone Pharmaceuticals Inc.
Jun 10, 2026
Award(A)
Stock Option (right to buy)
Direct
77K shares-
EYPT
EyePoint, Inc.
Jan 2, 2026
Award(A)
Stock Option (Right to Buy)
Direct
40K shares-
MIST
Milestone Pharmaceuticals Inc.
Jun 10, 2025
Award(A)
Stock Option (right to buy)
Direct
40K shares-
ACHV
ACHIEVE LIFE SCIENCES, INC.
Jun 6, 2025
Award(A)
Stock Option (right to buy)
Direct
31.5K shares-
FHTX
Foghorn Therapeutics Inc.
May 1, 2025
Award(A)
Stock Options (Right to buy)
Direct
50K shares at avg. $4.16-
EYPT
EyePoint Pharmaceuticals, Inc.
Jan 3, 2025
Award(A)
Stock Option (Right to Buy)
Direct
40K shares-

		Type	Shares	Price		Ownership
Jun 24, 2026	FHTX Foghorn Therapeutics Inc.	Award(A) Stock Options (Right to buy)	28,000	$4.08	-	Direct
Jun 10, 2026	MIST Milestone Pharmaceuticals Inc.	Award(A) Stock Option (right to buy)	77,000	-	-	Direct
Jan 2, 2026	EYPT EyePoint, Inc.	Award(A) Stock Option (Right to Buy)	40,000	-	-	Direct
Jun 10, 2025	MIST Milestone Pharmaceuticals Inc.	Award(A) Stock Option (right to buy)	40,000	-	-	Direct
Jun 6, 2025	ACHV ACHIEVE LIFE SCIENCES, INC.	Award(A) Stock Option (right to buy)	31,500	-	-	Direct
May 1, 2025	FHTX Foghorn Therapeutics Inc.	Award(A) Stock Options (Right to buy)	50,000	$4.16	-	Direct
Jan 3, 2025	EYPT EyePoint Pharmaceuticals, Inc.	Award(A) Stock Option (Right to Buy)	40,000	-	-	Direct

1-7 of 7 transactions

About Duty Stuart

Duty Stuart (SEC CIK 0001970274) files insider reports with the SEC as Director of Foghorn Therapeutics Inc. (FHTX), Director of Milestone Pharmaceuticals Inc. (MIST) and Director of EyePoint, Inc. (EYPT). Signal8 also holds filings tied to 1 other company.

Signal8 holds 8 ownership filings by Duty Stuart (1 Form 3, 7 Form 4), filed between Jan 7, 2025 and Jun 25, 2026. Those filings report 7 transactions, from Jan 3, 2025 to Jun 24, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Duty Stuart's filings is in MONTREAL.

Recent filings by Duty Stuart

Jun 24, 2026: Grant or award of FHTX derivative securities (Form 4, code A).
Jun 10, 2026: Grant or award of MIST derivative securities (Form 4, code A).
Jan 2, 2026: Grant or award of EYPT derivative securities (Form 4, code A).
Jun 10, 2025: Grant or award of MIST derivative securities (Form 4, code A).
Jun 6, 2025: Grant or award of ACHV derivative securities (Form 4, code A).

Other insiders filing for Foghorn Therapeutics Inc. (FHTX)

BVF PARTNERS L P/IL, 10% Owner
Lynch Thomas J. Jr., Director
Biller Scott, Director
Gallagher Neil, Director
Mendelsohn Michael, Director
SMITH IAN F, Director

How to read Form 4 transaction codes